Skip to Content

TAK ALG-12.5 (Alogliptin Benzoate 12.5 mg)

Pill with imprint TAK ALG-12.5 is Yellow, Elliptical / Oval and has been identified as Alogliptin Benzoate 12.5 mg. It is supplied by Perrigo New York Inc..

Alogliptin is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Alogliptin 12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TAK ALG-12.5

Alogliptin Benzoate

Imprint
TAK ALG-12.5
Strength
12.5 mg
Color
Yellow
Size
9.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Dipeptidyl peptidase 4 inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Perrigo New York Inc.
National Drug Code (NDC)
45802-0103
Inactive Ingredients
mannitol, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, hypromellose 2910 (6 mPa.s), titanium dioxide, polyethylene glycol 8000, ferric oxide yellow, ferrosoferric oxide, shellac, butyl alcohol, alcohol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "TAK ALG-12.5"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.